Trial intelligence / Profile preview

Liver Resection vs No Surgery in Colorectal Cancer with Liver and Lung Metastases

NCT02738606Phase 2Terminated

Sponsor
University of Texas MD Anderson Cancer Center
Start
Sep 2016
Primary completion
Dec 2025
Countries
1
01

Overview

Phase 2, randomised, open-label trial in colorectal cancer (CRC) (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Overall Survival. Started Sep 2016; status: terminated.

02

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02738606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02738606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call